Without policy intervention to address average sales price-based challenges to biosimilar market sustainability, there is a ...

The cost of tissue plasminogen activator (tPA), or alteplase, a clot-busting drug used to treat stroke patients, has doubled in the past decade, while reimbursement to hospitals for the use of tPA has ...

Today’s anesthesia leaders are navigating unprecedented financial pressure and structural change. With declining reimbursements, rising costs and shifting care models, anesthesia groups must maintain ...

The National Institutes of Health’s (NIH) plan to cut indirect cost reimbursement for NIH-funded research grants will have “a significantly disruptive impact on UB’s ability to carry out lifesaving ...

In a recent decision, the Civilian Board of Contract Appeals (CBCA) held that contractors performing loan-servicing work for the Department ...

Scientists cannot do science if they don't have laboratories in which to do it. That sort of in a nutshell, is what this case ...